Launching and marketing a biologic therapy is a complex and challenging process characterized by access, reimbursement, and distribution issues that differ considerably from that of traditional oral medications. The Strategyx staff has extensive knowledge and expertise in addressing these unique issues and developing the required strategies to successfully launch and market infusible and injectable biologic products. We specialize not only in preparing the external market for our client's product, but also in preparing our client's organizations to address the continually evolving private and public payer environments.